The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)
- First Posted Date
- 2024-09-05
- Last Posted Date
- 2024-09-05
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 144
- Registration Number
- NCT06585579
- Locations
- 🇫🇷
CHU Amiens-Picardie, Amiens, France
🇫🇷CHU Besançon, Besançon, France
🇫🇷Hôpital Nord Franche-Comté, Trévenans, France
Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 42
- Registration Number
- NCT06465472
Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-11
- Last Posted Date
- 2024-06-11
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 120
- Registration Number
- NCT06451913
Performance and Safety of MUCOGYNE® Ovule as a Moisturizer
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 50
- Registration Number
- NCT06282614
- Locations
- 🇫🇷
JEAN Christian's medical office, Nogent-sur-Marne, France
🇫🇷Dr Ramez GHADRI's medical office, Orléans, France
🇫🇷Dr Raïssa APERANO-MAS's medical office, Rennes, France
Evaluation of the Efficacy and Safety of Mucogye® Gel as a Moisturizer
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 50
- Registration Number
- NCT05913479
- Locations
- 🇫🇷
Dr Paul Lefevre's medical office, Caen, France
🇫🇷Dr Thierry KELLER's medical office, Colmar, France
🇫🇷Dr Christiane ARMAND's medical office, Écully, France
The Effect of Mucogyne® Gel on Wound Healing
- First Posted Date
- 2023-06-05
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 118
- Registration Number
- NCT05888194
- Locations
- 🇫🇷
CHU Lille, Lille, France
🇫🇷CHU Strasbourg, Strasbourg, France
🇫🇷CHU Montpellier, Montpellier, France
Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 48
- Registration Number
- NCT05735951
- Locations
- 🇧🇬
Mc Comac Medical, Sofia, Bulgaria
Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA
Completed
- Conditions
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 100
- Registration Number
- NCT05544058
- Locations
- 🇺🇸
Mayo clinic, Rochester, Minnesota, United States
Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies
- First Posted Date
- 2022-06-15
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 52
- Registration Number
- NCT05419180
- Locations
- 🇫🇷
Centre de Référence Epilepsies Rares / Centre Investigation Clinique (CIC) - Hôpital Necker-Enfants Malades, Paris, France
Effect of Ultra-gyn® on Vulvovaginal Candidiasis
- First Posted Date
- 2022-03-10
- Last Posted Date
- 2022-03-10
- Lead Sponsor
- Biocodex
- Target Recruit Count
- 30
- Registration Number
- NCT05273333
- Locations
- 🇲🇺
IR, Quatre Bornes, Mauritius
© Copyright 2024. All Rights Reserved by MedPath